JPWO2020264161A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020264161A5
JPWO2020264161A5 JP2021577862A JP2021577862A JPWO2020264161A5 JP WO2020264161 A5 JPWO2020264161 A5 JP WO2020264161A5 JP 2021577862 A JP2021577862 A JP 2021577862A JP 2021577862 A JP2021577862 A JP 2021577862A JP WO2020264161 A5 JPWO2020264161 A5 JP WO2020264161A5
Authority
JP
Japan
Prior art keywords
anamycin
liposomal
bag
saline
vial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021577862A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023523872A (ja
JP7830131B2 (ja
JP2023523872A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/039621 external-priority patent/WO2020264161A1/en
Publication of JP2023523872A publication Critical patent/JP2023523872A/ja
Publication of JPWO2020264161A5 publication Critical patent/JPWO2020264161A5/ja
Publication of JP2023523872A5 publication Critical patent/JP2023523872A5/ja
Application granted granted Critical
Publication of JP7830131B2 publication Critical patent/JP7830131B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021577862A 2019-06-28 2020-06-25 リポソーム化アナマイシンを再構成する方法 Active JP7830131B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962868190P 2019-06-28 2019-06-28
US62/868,190 2019-06-28
PCT/US2020/039621 WO2020264161A1 (en) 2019-06-28 2020-06-25 Method of reconstituting liposomal annamycin

Publications (4)

Publication Number Publication Date
JP2023523872A JP2023523872A (ja) 2023-06-08
JPWO2020264161A5 true JPWO2020264161A5 (https=) 2023-07-14
JP2023523872A5 JP2023523872A5 (https=) 2023-07-14
JP7830131B2 JP7830131B2 (ja) 2026-03-16

Family

ID=74061076

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021577862A Active JP7830131B2 (ja) 2019-06-28 2020-06-25 リポソーム化アナマイシンを再構成する方法

Country Status (15)

Country Link
US (2) US12257262B2 (https=)
EP (1) EP3990041B1 (https=)
JP (1) JP7830131B2 (https=)
KR (1) KR20220027941A (https=)
CN (2) CN114728101B (https=)
AU (2) AU2020302784A1 (https=)
BR (1) BR112021026480A2 (https=)
CA (1) CA3144443A1 (https=)
ES (1) ES3049663T3 (https=)
IL (1) IL289433B1 (https=)
MX (1) MX2021015667A (https=)
PL (1) PL3990041T3 (https=)
SG (1) SG11202113005SA (https=)
TW (2) TW202500161A (https=)
WO (1) WO2020264161A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3049663T3 (en) 2019-06-28 2025-12-17 Univ Texas Method of reconstituting liposomal annamycin
KR20220027969A (ko) 2019-06-28 2022-03-08 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 프리리포솜 아나마이신 동결건조물의 제조
KR20220103992A (ko) * 2019-11-21 2022-07-25 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 리포솜 아나마이신에 의한 폐 표적화 항암 요법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927571A (en) * 1987-05-18 1990-05-22 Liposome Technology, Inc. Preparation of injectable doxorubicin/liposome suspension
US4863739A (en) 1987-05-19 1989-09-05 Board Of Regents, The University Of Texas System Liposome compositions of anthracycline derivatives
IS1685B (is) * 1990-12-11 1998-02-24 Bracco International B.V. Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum
US5902604A (en) * 1995-06-06 1999-05-11 Board Of Regents, The University Of Texas System Submicron liposome suspensions obtained from preliposome lyophilizates
WO2001032145A1 (en) * 1999-10-29 2001-05-10 Board Of Regents, The University Of Texas System Method of cancer treatment
EP2314285B2 (en) * 2003-02-14 2019-09-18 Children's Hospital & Research Center at Oakland Lipophilic drug delivery vehicle and methods of use thereof
PL2544537T3 (pl) * 2010-03-10 2017-10-31 Cempra Pharmaceuticals Inc Pozajelitowe preparaty antybiotyków makrolidowych
WO2013055874A2 (en) * 2011-10-14 2013-04-18 Genentech, Inc. Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab
EP3572071A1 (en) * 2011-10-21 2019-11-27 Jazz Pharmaceuticals Research LLC Lyophilized liposomes
US8926994B2 (en) 2011-12-07 2015-01-06 The Methodist Hospital Research Institute Mesoporous silicon particles for the presentation of tumor antigens and adjuvant for anti-cancer immunity
ES2771926T3 (es) 2014-09-13 2020-07-07 Novartis Ag Terapias de combinación
AU2015327868A1 (en) 2014-10-03 2017-04-20 Novartis Ag Combination therapies
CN107569508A (zh) * 2016-07-05 2018-01-12 江苏竞诺择生物医药科技有限公司 一种治疗造血系统增殖性疾病的药用组合物
WO2018048752A1 (en) 2016-09-09 2018-03-15 Irisys, Inc. Lipsomal anticancer compositions
WO2019023873A1 (zh) * 2017-07-31 2019-02-07 江苏竞诺择生物医药科技有限公司 一种用于治疗造血系统增殖性疾病的纳米脂质微粒组合物及药用组合物
MA53565A (fr) 2018-09-04 2021-07-14 Minerva Neurosciences Inc Procédés d'utilisation d'un composé phénoxypropylamine pour le traitement de la douleur
ES3049663T3 (en) 2019-06-28 2025-12-17 Univ Texas Method of reconstituting liposomal annamycin
KR20220027969A (ko) 2019-06-28 2022-03-08 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 프리리포솜 아나마이신 동결건조물의 제조
KR20220103992A (ko) 2019-11-21 2022-07-25 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 리포솜 아나마이신에 의한 폐 표적화 항암 요법

Similar Documents

Publication Publication Date Title
US20230001396A1 (en) Compositions and methods for controlled delivery and protection of therapeutic agents
PL201329B1 (pl) Preparat farmaceutyczny w postaci koncentratu infuzyjnego
CA2871061C (en) Ready to be infused gemcitabine solution
AU2024203593B2 (en) Method of reconstituting liposomal annamycin
JPWO2020264161A5 (https=)
CN101874789B (zh) 含有兰索拉唑的冻干粉针
CN104971049B (zh) 一种含有福沙匹坦的冻干制剂及其制备方法
WO2020010616A1 (zh) 用于内镜手术的组合
CN102327224A (zh) 环磷腺苷脂质体注射剂及制备方法
CN105878193A (zh) 一种注射用兰索拉唑冻干粉及其制备方法
WO2024225432A1 (ja) Nmn凍結乾燥製剤の製造方法
WO2024079565A1 (en) Stable mitomycin concentrates
CN104958269B (zh) 一种兰索拉唑冻干乳剂及其制备方法
Baltazar et al. Instructional therapeutic toy used in children when using the peripherally inserted central catheter: family members’ perception
CN114712309A (zh) 一种人参皂苷多西他赛脂质体、其制备方法和应用
ES2324376T3 (es) Formulaciones farmaceuticas para administracion parenteral que comprenden epotilona.
CN115944597A (zh) 硫代寡核苷酸注射剂及其制备方法
CN108721209A (zh) 一种兽用阿奇霉素注射剂